In the experiments of siRNA silencing effects, we measured the suppression of Bcl-2 expression in B16/BL6 melanoma cells after delivering siRNA targeting Bcl-2 by MEL-A-containing cationic liposomes. The gene discussed is BCL2; the disease is melanoma.